ArticleDiabetic medicine : a journal of the British Diabetic Association2021

The cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands.

N Van der Linden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.